Over the past ten years, the VanEck Semiconductor ETF (SMH) has generated a staggering total return of 1,930%, equating to an annualized gain of roughly 35%. A $1,000 investment a decade ago, with dividends reinvested, would have swelled to approximately $20,300. By comparison, the S&P 500 ETF returned 14.9% annually over the same stretch, while the Nasdaq-100 ETF delivered around 20.6% — a wide gap that reflects the semiconductor sector’s powerful bull run even before the artificial intelligence boom fully took hold.
Those outsized rewards, however, have come with extreme turbulence. In the 2020s alone, SMH has suffered three drawdowns exceeding 30%. The fund now holds $67 billion in assets, with its top three positions — Nvidia, TSMC, and Broadcom — commanding a combined weight of more than 36%. Such concentration leaves the portfolio deeply exposed to the rhythm of the technology cycle, raising a critical question: can the explosive growth typical of an early-stage technological revolution persist in a straight line?
For investors shifting focus from pure capital appreciation toward building a long-term income engine, dividend ETFs present a different calculus. Two popular choices — the Vanguard Dividend Appreciation ETF (VIG) and the iShares Core Dividend Growth ETF (DGRO) — each carry notable weaknesses in the current environment. DGRO allocates around 21% to financials and nearly 18% to healthcare, two sectors confronting structural headwinds from potential regulatory overhauls and mounting cost pressures. VIG, meanwhile, has more than 26% in technology stocks, with Broadcom, Apple, and Microsoft alone accounting for nearly half that exposure. Heavily influenced by AI-driven valuation expansion among mega-caps, VIG offers a trailing dividend yield of just 1.5%, behaving more like a growth fund than a pure income vehicle.
The Schwab U.S. Dividend Equity ETF (SCHD) is built on a fundamentally different framework. Tracking the Dow Jones U.S. Dividend 100 Index, SCHD caps any single holding at 4% and rebalances quarterly to prevent sector imbalances. The index screens not only for five-year dividend growth and current yield, but also scores constituents on metrics such as cash flow and return on equity, ranking each stock against industry peers. The resulting portfolio features similarly sized positions in companies like Coca-Cola, Merck, Chevron, and Procter & Gamble — businesses rooted in stable demand, whose products and services are likely to remain relevant two decades from now. SCHD currently yields 3.3% with an expense ratio of just 0.06%.
The present market backdrop amplifies this contrast. The sudden explosion of AI, growing cost challenges in healthcare, and rising expectations of financial regulatory reform all threaten to disrupt portfolios heavily concentrated in technology, financials, or healthcare. SCHD, with deeper exposure to economy-wide stalwart sectors, naturally offers a buffer against these structural unknowns. For investors with a horizon of twenty years or more, the semiconductor ETF already prices in an enormous amount of optimism. SCHD’s design — and the stability it provides — may be a rare advantage in this unusual juncture for markets.
